The Achilles tendon: management of acute and chronic conditions

The primary objective of the article featured in the Australian Journal of General Practice revolves around the management of acute Achilles tendon ruptures within the primary care. The Achilles tendon, which is the largest and strongest tendon in the human body, is formed by the fusion of the gastrocnemius and soleus muscles, playing a crucial role in activities such as walking, running, and high-impact exercises. It is worth noting that this particular injury exhibits a bimodal distribution pattern, with the first peak observed among individuals aged 25⁠–⁠40 years who actively engage in high-energy sports, while the second peak occurs among those aged over 60 years. Furthermore, it is well-documented that the use of fluoroquinolone antibiotics, particularly ciprofloxacin, is associated with the development of Achilles tendinitis and subsequent rupture, typically with a latency period ranging from two to 60 days.
In order to validate the findings of a physical examination, the utilization of ultrasonography for assessing the condition proves to be a valuable diagnostic tool. Although the management of acute ruptures remains a topic of ongoing debate, emerging evidence suggests that supervised non-operative approaches yield highly favorable outcomes. As part of the treatment process, patients are required to have their ankle placed in a plantarflexed cast or a removable orthosis equipped with a heel wedge. Additionally, comprehensive rehabilitation protocols are reviewed by both surgeons and physiotherapists at the six-week and twelve-week marks following the initial injury. For a more detailed overview, it is recommended to refer to the original manuscript.